Skip to the page

Data / Form D filings / Akeso Biomedical, Inc.

Akeso Biomedical, Inc.: Form D filings

Akeso Biomedical, Inc., a company in Burlington, MA, filed 10 Form D notices with the SEC between 2014 and 2023. The latest, on June 6, 2023, reports $25,000 sold of a $200,000 offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2400 District Avenue, Suite 110, Burlington, MA, 01803
Phone
(781) 890-0088
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1604559

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 6, 2023New notice$200,000$25,000$175,0002May 29, 2023sec.gov
Feb 12, 2021New notice$1,000,000$573,905$426,09530Feb 5, 2021sec.gov
Nov 8, 2019New notice$3,000,000$597,325$2,402,67520Oct 28, 2019sec.gov
Dec 5, 2018Amendment$2,500,000$981,695$1,518,30551May 12, 2018sec.gov
May 18, 2018New notice$1,050,000$149,285$900,71517May 12, 2018sec.gov
Mar 17, 2017Amendment$5,000,000$2,515,000$2,485,00026Mar 31, 2016sec.gov
Mar 23, 2016New notice$5,000,000$0$5,000,0000Yet to occursec.gov
Jul 13, 2015New notice$1,000,000$535,000$465,00010Jul 10, 2015sec.gov
Dec 22, 2014New notice$500,000$225,000$275,0009Dec 22, 2014sec.gov
Apr 2, 2014New notice$250,000$0$250,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Greg W LeeDirector
Kevin Calvin OhashiDirector
Simon WilliamsExecutive Officer, Director
Scott J RothDirector
Robert Calvin GoforthDirector
Anthony J SinskeyDirector

Other companies in Massachusetts that filed recently

Every Form D from the week of Jun 5, 2023 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what Akeso Biomedical, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.